T1	Intervention 1 108	Treatment of hyperhomocysteinemia and endothelial dysfunction in renal-transplant recipients with vitamin B
T2	Intervention 353 501	vitamin treatment (group A, n = 18, folic acid 5 mg/d, vitamin B(6) 50 mg/d, B(12) 1000 microg/d) or controlled group (group B, n = 18) for 6 months
T3	Intervention 661 695	Endothelial function was evaluated
T4	Intervention 526 659	assessment of levels for creatinine, creatinine clearance, average pressure, total cholesterol, triglyceride and fasting homocysteine
